HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.

AbstractOBJECTIVE:
To investigate deep and comprehensive analysis of gut microbial communities and biological parameters after prebiotic administration in obese and diabetic mice.
RESEARCH DESIGN AND METHODS:
Genetic (ob/ob) or diet-induced obese and diabetic mice were chronically fed with prebiotic-enriched diet or with a control diet. Extensive gut microbiota analyses, including quantitative PCR, pyrosequencing of the 16S rRNA, and phylogenetic microarrays, were performed in ob/ob mice. The impact of gut microbiota modulation on leptin sensitivity was investigated in diet-induced leptin-resistant mice. Metabolic parameters, gene expression, glucose homeostasis, and enteroendocrine-related L-cell function were documented in both models.
RESULTS:
In ob/ob mice, prebiotic feeding decreased Firmicutes and increased Bacteroidetes phyla, but also changed 102 distinct taxa, 16 of which displayed a >10-fold change in abundance. In addition, prebiotics improved glucose tolerance, increased L-cell number and associated parameters (intestinal proglucagon mRNA expression and plasma glucagon-like peptide-1 levels), and reduced fat-mass development, oxidative stress, and low-grade inflammation. In high fat-fed mice, prebiotic treatment improved leptin sensitivity as well as metabolic parameters.
CONCLUSIONS:
We conclude that specific gut microbiota modulation improves glucose homeostasis, leptin sensitivity, and target enteroendocrine cell activity in obese and diabetic mice. By profiling the gut microbiota, we identified a catalog of putative bacterial targets that may affect host metabolism in obesity and diabetes.
AuthorsAmandine Everard, Vladimir Lazarevic, Muriel Derrien, Myriam Girard, Giulio G Muccioli, Giulio M Muccioli, Audrey M Neyrinck, Sam Possemiers, Ann Van Holle, Patrice François, Willem M de Vos, Nathalie M Delzenne, Jacques Schrenzel, Patrice D Cani
JournalDiabetes (Diabetes) Vol. 60 Issue 11 Pg. 2775-86 (Nov 2011) ISSN: 1939-327X [Electronic] United States
PMID21933985 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dietary Fats
  • Leptin
  • Prebiotics
  • RNA, Messenger
  • Proglucagon
  • Glucagon-Like Peptide 1
Topics
  • Animals
  • Cecum (microbiology)
  • Colon (metabolism, pathology)
  • Diabetes Mellitus, Type 2 (blood, diet therapy, metabolism, pathology)
  • Dietary Fats (adverse effects)
  • Enteroendocrine Cells (metabolism, pathology)
  • Gene Expression Regulation
  • Glucagon-Like Peptide 1 (blood)
  • Glucose Intolerance (prevention & control)
  • Gram-Negative Bacteria (classification, isolation & purification)
  • Gram-Positive Bacteria (classification, isolation & purification)
  • Hyperglycemia (prevention & control)
  • Hyperlipidemias (prevention & control)
  • Leptin (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Molecular Typing
  • Obesity (blood, diet therapy, metabolism, pathology)
  • Prebiotics
  • Proglucagon (genetics, metabolism)
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: